"Designing Growth Strategies is in our DNA"

Schizophrenia Drugs Market Size, Share & Industry Analysis, By Therapeutic Class (Second Generation, Third Generation, Others), By Treatment (Oral, Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others) and Regional Forecast, 2019-2032

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI101531

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Increasing Adoption of Long Acting Injectable (LAIs) as a Form of Treatment
    2. Prevalence of Schizophrenia Disorders by Key Regions
    3. New Product Launches
    4. Pipeline Analysis
    5. Regulatory Scenario By Key Regions
    6. Analysis of First Generation Antipsychotics versus Second & Third Generation Antipsychotics
    7. Overview of R&D Initiatives in Schizophrenia Treatment
  5. Global Schizophrenia Drugs Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Therapeutic Class
      1. Third Generation Antipsychotics
      2. Second Generation Antipsychotics
      3. Others
    3. Market Analysis, Insights and Forecast – By Treatment
      1. Oral
      2. Injectable
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    5. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Schizophrenia Drugs Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Therapeutic Class
      1. Third Generation Antipsychotics
      2. Second Generation Antipsychotics
      3. Others
    3. Market Analysis – By Treatment
      1. Oral
      2. Injectable
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    5. Market Analysis – By Country
      1. U.S.
      2. Canada
  7. Europe Schizophrenia Drugs Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Therapeutic Class
      1. Third Generation Antipsychotics
      2. Second Generation Antipsychotics
      3. Others
    3. Market Analysis – By Treatment
      1. Oral
      2. Injectable
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    5. Market Analysis – By Country/ Sub-Region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Schizophrenia Drugs Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Therapeutic Class
      1. Third Generation Antipsychotics
      2. Second Generation Antipsychotics
      3. Others
    3. Market Analysis – By Treatment
      1. Oral
      2. Injectable
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    5. Market Analysis – By Country/ Sub-Region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Schizophrenia Drugs Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Therapeutic Class
      1. Third Generation Antipsychotics
      2. Second Generation Antipsychotics
      3. Others
    3. Market Analysis – By Treatment
      1. Oral
      2. Injectable
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    5. Market Analysis – By Country/ Sub-Region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Schizophrenia Drugs Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Therapeutic Class
      1. Third Generation Antipsychotics
      2. Second Generation Antipsychotics
      3. Others
    3. Market Analysis – By Treatment
      1. Oral
      2. Injectable
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    5. Market Analysis – By Country/ Sub-Region
      1. GCC Countries
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2018)
    3. Competition Dashboard
    4. Comparative Analysis – Major Players
    5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
      1. H. Lundbeck A/S
      2. Otsuka Pharmaceutical Co., Ltd.
      3. Janssen Pharmaceuticals, Inc.
      4. Eli Lilly and Company
      5. AstraZeneca
      6. ALLERGAN
      7. Vanda Pharmaceuticals Inc.
      8. Sumitomo Dainippon Pharma Co., Ltd.
      9. Alkermes plc
      10. Bristol-Myers Squibb Company
      11. Other Prominent Players
  12. Strategic Recommendations

 

Read Less

Figure 1:  Global Schizophrenia Drugs Market Revenue Breakdown (US$ Mn, %) by Region, 2018 & 2026

Figure 2:  Global Schizophrenia Drugs Market Value Share (%), by Therapeutic Class, 2018 & 2026

Figure 3:  Global Schizophrenia Drugs Market Forecast (US$ Mn), by Second Generation, 2015-2026

Figure 4:  Global Schizophrenia Drugs Market Forecast (US$ Mn), by Third Generation, 2015-2026

Figure 5:  Global Schizophrenia Drugs Market Forecast (US$ Mn), by Others, 2015-2026

Figure 6:  Global Schizophrenia Drugs Market Value Share (%), by Treatment, 2018 & 2026

Figure 7:  Global Schizophrenia Drugs Market Forecast (US$ Mn), by Oral, 2015-2026

Figure 8:  Global Schizophrenia Drugs Market Forecast (US$ Mn), by Injectable, 2015-2026

Figure 9:  Global Schizophrenia Drugs Market Value Share (%), by Distribution Channel, 2018 & 2026

Figure 10:  Global Schizophrenia Drugs Market Forecast (US$ Mn), by Hospital Pharmacies, 2015-2026

Figure 11:  Global Schizophrenia Drugs Market Forecast (US$ Mn), by Retail Pharmacies, 2015-2026

Figure 12:  Global Schizophrenia Drugs Market Forecast (US$ Mn), by Online Pharmacies, 2015-2026

Figure 13:  Global Schizophrenia Drugs Market Forecast (US$ Mn), by Others, 2015-2026

Figure 14:  Global Schizophrenia Drugs Market Value (US$ Mn), by Region, 2018 & 2026

Figure 15:  North America Schizophrenia Drugs Market Value (US$ Mn), by Therapeutic Class, 2018 & 2026

Figure 16:  North America Schizophrenia Drugs Market Value Share (%), by Therapeutic Class, 2018

Figure 17:  North America Schizophrenia Drugs Market Value (US$ Mn), by Treatment, 2018 & 2026

Figure 18:  North America Schizophrenia Drugs Market Value Share (%), by Treatment, 2018

Figure 19:  North America Schizophrenia Drugs Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 20:  North America Schizophrenia Drugs Market Value Share (%), by Distribution Channel, 2018

Figure 21:  North America Schizophrenia Drugs Market Value (US$ Mn), By Country, 2018 & 2026

Figure 22:  North America Schizophrenia Drugs Market Value Share (%), By Country, 2018

Figure 23:  Europe Schizophrenia Drugs Market Value (US$ Mn), by Therapeutic Class, 2018 & 2026

Figure 24:  Europe Schizophrenia Drugs Market Value Share (%), by Therapeutic Class, 2018

Figure 25:  Europe Schizophrenia Drugs Market Value (US$ Mn), by Treatment, 2018 & 2026

Figure 26:  Europe Schizophrenia Drugs Market Value Share (%), by Treatment, 2018

Figure 27:  Europe Schizophrenia Drugs Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 28:  Europe Schizophrenia Drugs Market Value Share (%), by Distribution Channel, 2018

Figure 29:  Europe Schizophrenia Drugs Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 30:  Europe Schizophrenia Drugs Market Value Share (%), By Country/ Sub-region, 2018

Figure 31:  Asia Pacific Schizophrenia Drugs Market Value (US$ Mn), by Therapeutic Class, 2018 & 2026

Figure 32:  Asia Pacific Schizophrenia Drugs Market Value Share (%), by Therapeutic Class, 2018

Figure 33:  Asia Pacific Schizophrenia Drugs Market Value (US$ Mn), by Treatment, 2018 & 2026

Figure 34:  Asia Pacific Schizophrenia Drugs Market Value Share (%), by Treatment, 2018

Figure 35:  Asia Pacific Schizophrenia Drugs Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 36:  Asia Pacific Schizophrenia Drugs Market Value Share (%), by Distribution Channel, 2018

Figure 37:  Asia Pacific Schizophrenia Drugs Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 38:  Asia Pacific Schizophrenia Drugs Market Value Share (%), By Country/ Sub-region, 2018

Figure 39:  Latin America Schizophrenia Drugs Market Value (US$ Mn), by Therapeutic Class, 2018 & 2026

Figure 40:  Latin America Schizophrenia Drugs Market Value Share (%), by Therapeutic Class, 2018

Figure 41:  Latin America Schizophrenia Drugs Market Value (US$ Mn), by Treatment, 2018 & 2026

Figure 42:  Latin America Schizophrenia Drugs Market Value Share (%), by Treatment, 2018

Figure 43:  Latin America Schizophrenia Drugs Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 44:  Latin America Schizophrenia Drugs Market Value Share (%), by Distribution Channel, 2018

Figure 45:  Latin America Schizophrenia Drugs Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 46:  Latin America Schizophrenia Drugs Market Value Share (%), By Country/ Sub-region, 2018

Figure 47:  Middle East & Africa Schizophrenia Drugs Market Value (US$ Mn), by Therapeutic Class, 2018 & 2026

Figure 48:  Middle East & Africa Schizophrenia Drugs Market Value Share (%), by Therapeutic Class, 2018

Figure 49:  Middle East & Africa Schizophrenia Drugs Market Value (US$ Mn), by Treatment, 2018 & 2026

Figure 50:  Middle East & Africa Schizophrenia Drugs Market Value Share (%), by Treatment, 2018

Figure 51:  Middle East & Africa Schizophrenia Drugs Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 52:  Middle East & Africa Schizophrenia Drugs Market Value Share (%), by Distribution Channel, 2018

Figure 53:  Middle East & Africa Schizophrenia Drugs Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 54:  Middle East & Africa Schizophrenia Drugs Market Value Share (%), By Country/ Sub-region, 2018

Figure 55:  Global Schizophrenia Drugs Market Share (%), By Company, 2018

 

Table 1:  Global Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Therapeutic Class, 2015–2026

Table 2:  Global Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Treatment, 2015–2026

Table 3:  Global Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015–2026

Table 4:  Global Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Region, 2015-2026

Table 5:  North America Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Therapeutic Class, 2015-2026

Table 6:  North America Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Treatment, 2015-2026

Table 7:  North America Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 8:  North America Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, By Country, 2015-2026

Table 9:  Europe Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Therapeutic Class, 2015-2026

Table 10:  Europe Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Treatment, 2015-2026

Table 11:  Europe Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 12:  Europe Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 13:  Asia Pacific Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Therapeutic Class, 2015-2026

Table 14:  Asia Pacific Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Treatment, 2015-2026

Table 15:  Asia Pacific Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 16:  Asia Pacific Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 17:  Latin America Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Therapeutic Class, 2015-2026

Table 18:  Latin America Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Treatment, 2015-2026

Table 19:  Latin America Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 20:  Latin America Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 21:  Middle East & Africa Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Therapeutic Class, 2015-2026

Table 22:  Middle East & Africa Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Treatment, 2015-2026

Table 23:  Middle East & Africa Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 24:  Middle East & Africa Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Schizophrenia Drugs Market Size, Share and Global Industry Trend Forecast till 2032
  • REPORT UPDATE
    IN PROCESS
  • 2019-2032
    (In Process)
  • 2023
    (In Process)
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase
Healthcare Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann